Biblioteca CRAI Dulce Chacón - Universidad Europea de Madrid

CRAI Library - Madrid
Your cart is empty.
My folder ( items) | My account
Image from Google Jackets

Handbook of relapsing-remitting multiple sclerosis / Aaron Miller, editor.

Contributor(s): Miller, Aaron E.,, editor literario
Material type: materialTypeLabelE-bookPublisher: Cham, Switzerland : Adis, 2017Description: 1 recurso en línea.ISBN: 3319406280; 9783319406282.Subject: Esclerosis múltipleOnline resources: Acceso a este recurso digital (usuarios Universidad Europea de Madrid)Digital Resources
Contents:
Preface; Contents; Contributors; Chapter 1: Multiple Sclerosis: An Overview; 1.1 Introduction; 1.2 Epidemiology and Risk Factors; References; Chapter 2: The Pathophysiology and Clinical Presentation of Multiple Sclerosis; 2.1 Introduction; 2.2 Etiology of Multiple Sclerosis; 2.2.1 Autoimmunity; 2.2.2 Genetics; 2.2.3 Infectious; 2.2.4 Degenerative; 2.3 Pathophysiologic Mechanisms of Multiple Sclerosis; 2.4 White Matter Plaque Formation; 2.5 Blood-Brain Barrier Breakdown, Leukocyte Entry, Demyelination, and Axonal Injury; 2.6 Cortical Demyelination.
2.7 Diffuse White Matter Changes, Global Atrophy, and Progressive Degeneration2.8 Remyelination and Repair; 2.9 The Clinical Presentation of Multiple Sclerosis; 2.10 Common Symptoms; 2.10.1 Fatigue; 2.10.2 Cognitive Dysfunction; 2.10.3 Mood Symptoms; 2.10.4 Optic Neuritis; 2.10.5 Brainstem and Cerebellar Symptoms; 2.10.6 Sensory Disturbances; 2.10.7 Motor Symptoms; 2.10.8 Bladder, Bowel, and Sexual Dysfunction; 2.11 Conclusion; References; Chapter 3: Assessment and Diagnosis of Relapsing Multiple Sclerosis; 3.1 Introduction.
3.2 Patient History and Clinical Relapses in Establishing a Diagnosis3.3 Role of MRI in Establishing a Diagnosis; 3.4 Patients Who Do Not Meet Full Diagnostic Criteria: Clinically Isolated Syndrome and Radiologically Isolated Syndrome; 3.4.1 Clinically Isolated Syndrome; 3.4.2 Radiologically Isolated Syndrome; 3.5 Role of Ancillary Testing in Establishing a Diagnosis (CSF Analysis and Evoked Potentials); 3.6 Assessment Scales; 3.7 Patient Counseling and Education; 3.8 Differential Diagnosis; 3.9 Neuromyelitis Optica Spectrum Disorders; 3.10 Acute Disseminated Encephalomyelitis; References.
5.2 New Monoclonal Antibodies5.2.1 Daclizumab; 5.2.2 Ocrelizumab; 5.3 Remyelination and Repair; 5.3.1 Anti-LINGO-1; 5.4 Stem Cell Therapeutics; 5.4.1 Hematopoietic Stem Cell Transplantation; 5.4.2 Mesenchymal Stem Cell Transplantation; Intravenous Mesenchymal Stem Cell Application; Intrathecal Mesenchymal Stem Cell Application; 5.4.3 Glial Progenitor Cell Transplantation; References; Chapter 6: Symptom Management in Multiple Sclerosis; 6.1 Introduction; 6.2 Fatigue; 6.3 Sensory Deficits and Pain; 6.4 Motor and Balance Issues; 6.5 Visual Deficits; 6.6 Bladder, Bowel, and Sexual Issues.
Chapter 4: Treatment Strategies in Multiple Sclerosis4.1 Introduction; 4.2 Initiating Therapy; 4.3 Disease-Modifying Therapies; 4.3.1 Interferons; 4.3.2 Glatiramer Acetate; 4.3.3 Natalizumab; 4.3.4 Fingolimod; 4.3.5 Teriflunomide; 4.3.6 Dimethyl Fumarate; 4.3.7 Alemtuzumab; 4.3.8 Mitoxantrone; 4.4 Switching Disease-Modifying Therapies; 4.5 Acute Treatment of Relapses; 4.6 Treatment of Multiple Sclerosis During Pregnancy; 4.7 Treatment of Pediatric Multiple Sclerosis; 4.8 Conclusion; References; Chapter 5: Emerging Therapies in Multiple Sclerosis; 5.1 Introduction.
Abstract: This pocketbook is an evidence-based educational resource that provides a concise overview of diagnosis, treatment and long-term management of relapsing-remitting multiple sclerosis. An ideal clinical handbook for a wide range of medical professionals, this handbook includes international guidelines, clinically relevant clinical trial data, and an introduction to emerging therapies. Handbook of Relapsing-Remitting Multiple Sclerosis is a comprehensive overview of recent advances in this indication, enhanced by high quality figures and clinical images.
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Collection Call number Status Date due Barcode Item holds
LIBRO-E NO PRÉSTAMO LIBRO-E NO PRÉSTAMO Madrid Digital Acceso Electrónico (UEM) Ciencias de la Salud RC377 .H363 2017 EB (Browse shelf(Opens below)) Acceso electrónico eBook.20022927
Total holds: 0

Preface; Contents; Contributors; Chapter 1: Multiple Sclerosis: An Overview; 1.1 Introduction; 1.2 Epidemiology and Risk Factors; References; Chapter 2: The Pathophysiology and Clinical Presentation of Multiple Sclerosis; 2.1 Introduction; 2.2 Etiology of Multiple Sclerosis; 2.2.1 Autoimmunity; 2.2.2 Genetics; 2.2.3 Infectious; 2.2.4 Degenerative; 2.3 Pathophysiologic Mechanisms of Multiple Sclerosis; 2.4 White Matter Plaque Formation; 2.5 Blood-Brain Barrier Breakdown, Leukocyte Entry, Demyelination, and Axonal Injury; 2.6 Cortical Demyelination.

2.7 Diffuse White Matter Changes, Global Atrophy, and Progressive Degeneration2.8 Remyelination and Repair; 2.9 The Clinical Presentation of Multiple Sclerosis; 2.10 Common Symptoms; 2.10.1 Fatigue; 2.10.2 Cognitive Dysfunction; 2.10.3 Mood Symptoms; 2.10.4 Optic Neuritis; 2.10.5 Brainstem and Cerebellar Symptoms; 2.10.6 Sensory Disturbances; 2.10.7 Motor Symptoms; 2.10.8 Bladder, Bowel, and Sexual Dysfunction; 2.11 Conclusion; References; Chapter 3: Assessment and Diagnosis of Relapsing Multiple Sclerosis; 3.1 Introduction.

3.2 Patient History and Clinical Relapses in Establishing a Diagnosis3.3 Role of MRI in Establishing a Diagnosis; 3.4 Patients Who Do Not Meet Full Diagnostic Criteria: Clinically Isolated Syndrome and Radiologically Isolated Syndrome; 3.4.1 Clinically Isolated Syndrome; 3.4.2 Radiologically Isolated Syndrome; 3.5 Role of Ancillary Testing in Establishing a Diagnosis (CSF Analysis and Evoked Potentials); 3.6 Assessment Scales; 3.7 Patient Counseling and Education; 3.8 Differential Diagnosis; 3.9 Neuromyelitis Optica Spectrum Disorders; 3.10 Acute Disseminated Encephalomyelitis; References.

5.2 New Monoclonal Antibodies5.2.1 Daclizumab; 5.2.2 Ocrelizumab; 5.3 Remyelination and Repair; 5.3.1 Anti-LINGO-1; 5.4 Stem Cell Therapeutics; 5.4.1 Hematopoietic Stem Cell Transplantation; 5.4.2 Mesenchymal Stem Cell Transplantation; Intravenous Mesenchymal Stem Cell Application; Intrathecal Mesenchymal Stem Cell Application; 5.4.3 Glial Progenitor Cell Transplantation; References; Chapter 6: Symptom Management in Multiple Sclerosis; 6.1 Introduction; 6.2 Fatigue; 6.3 Sensory Deficits and Pain; 6.4 Motor and Balance Issues; 6.5 Visual Deficits; 6.6 Bladder, Bowel, and Sexual Issues.

Chapter 4: Treatment Strategies in Multiple Sclerosis4.1 Introduction; 4.2 Initiating Therapy; 4.3 Disease-Modifying Therapies; 4.3.1 Interferons; 4.3.2 Glatiramer Acetate; 4.3.3 Natalizumab; 4.3.4 Fingolimod; 4.3.5 Teriflunomide; 4.3.6 Dimethyl Fumarate; 4.3.7 Alemtuzumab; 4.3.8 Mitoxantrone; 4.4 Switching Disease-Modifying Therapies; 4.5 Acute Treatment of Relapses; 4.6 Treatment of Multiple Sclerosis During Pregnancy; 4.7 Treatment of Pediatric Multiple Sclerosis; 4.8 Conclusion; References; Chapter 5: Emerging Therapies in Multiple Sclerosis; 5.1 Introduction.

This pocketbook is an evidence-based educational resource that provides a concise overview of diagnosis, treatment and long-term management of relapsing-remitting multiple sclerosis. An ideal clinical handbook for a wide range of medical professionals, this handbook includes international guidelines, clinically relevant clinical trial data, and an introduction to emerging therapies. Handbook of Relapsing-Remitting Multiple Sclerosis is a comprehensive overview of recent advances in this indication, enhanced by high quality figures and clinical images.

There are no comments on this title.

to post a comment.
Share